Skip to main content
Premium Trial:

Request an Annual Quote

Beyond Genomics Taps Sepracor Exec to be First CSO

NEW YORK, June 20 - Beyond Genomics said yesterday it has chosen Jim Hauske to become its first chief scientific officer.


Hauske, who started on Monday, comes to Beyond Genomics from Sepracor where he was senior vice president for discovery.


Hauske said he expects to help Beyond Genomics build a drug-discovery group in several therapeutic areas. "I'm going to intercept Beyond Genomics' technology with drug-design and drug-development skills that will allow us to more rapidly enter the therapeutic area that the organization cares about," he told GenomeWeb.


Currently the therapeutic areas considered are CNS, oncology, and cardiovascular disorders, according to Stephen Ober, Beyond Genomics' president. "We haven't made a commitment to any area in particular at this point," Ober added.


Click here for more information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.